These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19494293)

  • 1. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation.
    Peter ME; Kubarenko AV; Weber AN; Dalpke AH
    J Immunol; 2009 Jun; 182(12):7690-7. PubMed ID: 19494293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-induced conformational changes allosterically activate Toll-like receptor 9.
    Latz E; Verma A; Visintin A; Gong M; Sirois CM; Klein DC; Monks BG; McKnight CJ; Lamphier MS; Duprex WP; Espevik T; Golenbock DT
    Nat Immunol; 2007 Jul; 8(7):772-9. PubMed ID: 17572678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides.
    Brownlie R; Zhu J; Allan B; Mutwiri GK; Babiuk LA; Potter A; Griebel P
    Mol Immunol; 2009 Sep; 46(15):3163-70. PubMed ID: 19573927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9.
    Keestra AM; de Zoete MR; Bouwman LI; van Putten JP
    J Immunol; 2010 Jul; 185(1):460-7. PubMed ID: 20498358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.
    Rutz M; Metzger J; Gellert T; Luppa P; Lipford GB; Wagner H; Bauer S
    Eur J Immunol; 2004 Sep; 34(9):2541-50. PubMed ID: 15307186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-length sequence and expression analysis of Toll-like receptor 9 in the gilthead seabream (Sparus aurata L.).
    Franch R; Cardazzo B; Antonello J; Castagnaro M; Patarnello T; Bargelloni L
    Gene; 2006 Aug; 378():42-51. PubMed ID: 16797882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
    Yasuda K; Rutz M; Schlatter B; Metzger J; Luppa PB; Schmitz F; Haas T; Heit A; Bauer S; Wagner H
    Eur J Immunol; 2006 Feb; 36(2):431-6. PubMed ID: 16421948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
    Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
    Bauer S; Kirschning CJ; Häcker H; Redecke V; Hausmann S; Akira S; Wagner H; Lipford GB
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9237-42. PubMed ID: 11470918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
    Merrell MA; Ilvesaro JM; Lehtonen N; Sorsa T; Gehrs B; Rosenthal E; Chen D; Shackley B; Harris KW; Selander KS
    Mol Cancer Res; 2006 Jul; 4(7):437-47. PubMed ID: 16849519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission.
    Takada E; Okahira S; Sasai M; Funami K; Seya T; Matsumoto M
    Mol Immunol; 2007 Jul; 44(15):3633-40. PubMed ID: 17521732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and characterization of equine Toll-like receptor 9.
    Zhang YW; Davis EG; Blecha F; Wilkerson MJ
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):209-19. PubMed ID: 18462806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous Thr 135 Ala polymorphism at leucine-rich repeat (LRR) in genomic DNA of toll-like receptor 4 in patients with poorly-differentiated gastric adenocarcinomas.
    Ohara T; Morishita T; Suzuki H; Hibi T
    Int J Mol Med; 2006 Jul; 18(1):59-63. PubMed ID: 16786156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.
    Haas T; Metzger J; Schmitz F; Heit A; Müller T; Latz E; Wagner H
    Immunity; 2008 Mar; 28(3):315-23. PubMed ID: 18342006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR9-dependent systemic interferon-beta production by intravenous injection of plasmid DNA/cationic liposome complex in mice.
    Yoshida H; Nishikawa M; Yasuda S; Mizuno Y; Toyota H; Kiyota T; Takahashi R; Takakura Y
    J Gene Med; 2009 Aug; 11(8):708-17. PubMed ID: 19462411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross talk between Leishmania donovani CpG DNA and Toll-like receptor 9: an immunoinformatics approach.
    Gupta CL; Akhtar S; Waye A; Pandey NR; Pathak N; Bajpai P
    Biochem Biophys Res Commun; 2015 Apr; 459(3):424-9. PubMed ID: 25735984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal binding site in the human toll-like receptor 3 ectodomain.
    Watanabe T; Tokisue T; Tsujita T; Matsumoto M; Seya T; Nishikawa S; Hasegawa T; Fukuda K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):405-6. PubMed ID: 18029758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsins are required for Toll-like receptor 9 responses.
    Matsumoto F; Saitoh S; Fukui R; Kobayashi T; Tanimura N; Konno K; Kusumoto Y; Akashi-Takamura S; Miyake K
    Biochem Biophys Res Commun; 2008 Mar; 367(3):693-9. PubMed ID: 18166152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
    Suwarti S; Yamazaki T; Svetlana C; Hanagata N
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG toll-like receptor 9 agonists.
    Jurk M; Kritzler A; Debelak H; Vollmer J; Krieg AM; Uhlmann E
    ChemMedChem; 2006 Sep; 1(9):1007-14. PubMed ID: 16952134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.